Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein e knockout mice independently of serum cholesterol level

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 4, 2011, Pages 800-807

  Wang, Ke Yong ^a   Tanimoto, Akihide ^a,b   Guo, Xin ^a   Yamada, Sohsuke ^a   Shimajiri, Shohei ^a   Murata, Yoshitaka ^c   Ding, Yan ^a   Tsutsui, Masato ^d   Kato, Seiya ^e   Watanabe, Teruo ^f   Ohtsu, Hiroshi ^g   Hirano, Ken Ichi ^h   Kohno, Kimitoshi ^a   Sasaguri, Yasuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Kyurin Corporation   (Japan)

^d Department of Pharmacology ^*  (Japan)

^e UNIVERSITY OF THE RYUKYUS   (Japan)

^f FUKUOKA WAJIRO HOSPITAL   (Japan)

^g TOHOKU UNIVERSITY   (Japan)

^h OSAKA UNIVERSITY   (Japan)

Author keywords

histamine; histidine decarboxylase; hyperlipidemia induced atherosclerosis; inflammation; matrix metalloproteinase

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CYTOKINE; HISTAMINE; HISTAMINE RECEPTOR; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; SCAVENGER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; CHOLESTEROL; CHOLESTEROL, DIETARY; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENOTYPE; HISTAMINE; HISTIDINE DECARBOXYLASE; HYPERLIPIDEMIAS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PHENOTYPE; RECEPTORS, HISTAMINE; RECEPTORS, SCAVENGER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953761637     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.215228     Document Type: Article

References (46)

1. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest. 2006;116:607-614. (Pubitemid 43326865)
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol. 1990;86:599-605.
4. Brzozowski T, Konturek PC, Konturek SJ, Kwiecień S, Pajdo R, Drozdowicz D, Ptak A, Pawlik M, Hahn EG. Involvement of gastrin in gastric secretory and protective actions of N-methyl histamine. J Physiol (Paris). 2001;95:89-98. (Pubitemid 33020223)
5. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ II, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med. 1985;313:1138-1141. (Pubitemid 16216831)
6. Laine P, Kaartinen M, Penttila A, Panulä P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999;99: 361-369. (Pubitemid 29051261)
7. Steffel J, Akhmedov A, Greutert H, Lüscher TF, Tanner FC. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation. 2005;112:341-349. (Pubitemid 41022074)
8. Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G. Allergic Rhinitis, Asthma, and Atherosclerosis in the Bruneck and ARMY Studies. Arch Intern Med. 2005;165:2521-2526. (Pubitemid 41720015)
9. Iribarren C, Tolstykh IV, Eisner MD. Are patients with asthma at increased risk of coronary heart disease? Int J Epidemiol. 2004;33: 743-748. (Pubitemid 39263849)
10. Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med. 2002;6: 583-592. (Pubitemid 44146436)
11. Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, Ohtsu H. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res. 2005;96:974-981. (Pubitemid 40712797)
12. Takagishi T, Sasaguri Y, Nakano R, Arima N, Tanimoto A, Fukui H, Morimatsu M. Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am J Pathol. 1995;146:981-988.
13. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol. 2007;27:1159-1165. (Pubitemid 46641972)
14. Higuchi S, Tanimoto A, Arima N, Xu H, Murata Y, Hamada T, Makishima K, Sasaguri Y. Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett. 2001;505:217-222. (Pubitemid 32896669)
15. Murata Y, Tanimoto A, Wang K-Y, Tsutsui M, Sasaguri Y, Corte FD, Matsushita H. Granulocyte macrophage- colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/ macrophages in relation to arteriosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:430-435. (Pubitemid 40189169)
16. Wang KY, Arima N, Higuchi S, Shimajiri S, Tanimoto A, Murata Y, Hamada T, Sasaguri Y. Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett. 2000;473:345-348. (Pubitemid 30249152)
17. Tanimoto A, Murata Y, Nomaguchi M, Kimura S, Arima N, Xu H, Hamada T, Sasaguri Y. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. FEBS Lett. 2001;508: 345-349. (Pubitemid 33135468)
18. Tanimoto A, Sasaguri Y, Ohtsu H. Histamine network in atherosclerosis. Trends Cardiovasc Med. 2006;16:280-284. (Pubitemid 44572804)
19. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, Tchougounova E, Hellman L, Gertsenstein M, Hirasawa N, Sakurai E, Buzás E, Kovács P, Csaba G, Kittel Á, Okada M, Hara M, Mar L, Numayama-Tsuruta K, Ishigaki-Suzuki S, Ohuchi K, Ichikawa A, Falus A, Watanabe T, Nagy A. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001;502:53-56. (Pubitemid 32722059)
20. Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, Kitajima S, Morimoto M, Tsutsui M, Watanabe T, Yasumoto K, Sasaguri Y. Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am J Pathol. 2008;172:1419-1429. (Pubitemid 351671554)
21. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res. 2002;43:805-814. (Pubitemid 34477908)
22. Gough PJ, Greaves DR, Suzuki H, Hakkinen T, Hiltunen MO, Turunen M, Herttuala SY, Kodama T, Gordon S. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1999;19:461-471. (Pubitemid 29135143)
23. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 1996;271:518-520.
24. Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest. 2009;119:136-145.
25. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-77. (Pubitemid 27130922)
26. Tanimoto A, Wang KY, Murata Y, Kimura S, Nomaguchi M, Nakata S, Tsutui M, Sasaguri Y. Histamine upregulates the expression of inducible nitric oxide synthase in human intimal smooth muscle cells via histamine H1 receptor and NFB signaling pathway. Arterioscler Thromb Vasc Biol. 2007;27:1556-1561. (Pubitemid 46986110)
27. Sasaguri Y, Yanagi H, Nagase H, Nakano R, Fukuda S, Morimatsu M. Collagenase production by immortalized human aortic endothelial cells infected with simian virus 40. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60:91-97.
28. Sasaguri Y, Murahashi N, Sugama K, Kato S, Hiraoka K, Satoh T, Isomoto H, Morimatsu M. Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab Invest. 1994;71:261-269. (Pubitemid 24278179)
29. Trigatti B, Rayburn H, Vinals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA. 1999;96:9322-9327. (Pubitemid 29374753)
30. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Mammer RE, Herz J. Hypercholesterolemis in low density lipoprotine receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92:883-893. (Pubitemid 23262411)
31. Osono Y, Woollett LA, Herz J, Dietschy JM. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissue of the mouse. J Clin Invest. 1995;95:1124-1132.
32. Wang KY, Tanimoto A, Yamada S, Guo X, Ding Y, Watanabe T, Watanabe T, Kohno K, Hirano K, Tsukada H. Sasaguri Y. Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice. Am J Pathol. 2010;177:713-723.
33. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Yakeya M, Schnackenberg L, Berger R, Hermonat PL, Thomas M, Sawamura T. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007;100:1634-1642. (Pubitemid 46897266)
34. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 2009;29:19-26.
35. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169-1196. (Pubitemid 38802622)
36. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454:470-477.
37. Kimura S, Wang KY, Tanimoto A, Murata Y, Nakashima Y, Sasaguri Y. Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis. Pathol Int. 2004;54:465-474. (Pubitemid 38951662)
38. Tanimoto A, Murata Y, Wang KY, Tsutsui M, Kohno K, Sasaguri Y. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via jak2-stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells. J Biol Chem. 2008;283:4 643-4651.
39. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998;18:842-851. (Pubitemid 28267666)
40. Ni W, Egashira K, Kitamoto S, Kataoka C, Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida KI, Takeshita A. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2001;103:2096-2101. (Pubitemid 32373014)
41. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 2004;109: 1408-1414. (Pubitemid 38387828)
42. Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest. 2006;116:59-69. (Pubitemid 43121791)
43. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A. Effect of MMP-2-deficiency on atherosclerotic lesion formation in apoEdeficient mice. Arterioscler Thromb Vasc Biol. 2006;26:1120-1125. (Pubitemid 43732121)
44. Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res. 2008;79:287-293. (Pubitemid 351951615)
45. de Winther MPJ, Kanters E, Kraal G, Hofker MH. Nuclear factoRB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25: 904-914.
46. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Bauerle PA, Neumeier D. Activated transcriptional factor nuclear factorB is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722. (Pubitemid 26105480)